FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q1 2021

SEC EDGAR SourceSEC Filings

Top Holdings237 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
SPYSPY
PUT

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

2.2M$885.8M4.4%
Increased
ALXNALXNDelisted

ALEXION PHARMACEUTICALS INC

5.8M$883.1M4.4%
2 qtrssince 2020-Q4
Increased
94

ALPHABET INC-CL C

404,351$836.5M4.2%$67.09+52.04%
10 qtrssince 2018-Q4
Increased
65

IQVIA HOLDINGS INC

4.1M$785.9M3.9%$125.89+51.55%
10 qtrssince 2018-Q4
Increased
58

WILLIS TOWERS WATSON PLC

3.1M$715.1M3.6%$210.43+3.67%
3 qtrssince 2020-Q3
Increased
94

AON PLC

2.5M$564.7M2.8%$191.13+15.94%
4 qtrssince 2020-Q2
Increased
58

THERMO FISHER SCIENTIFIC INC

1.2M$527.2M2.6%$317.72+40.33%
6 qtrssince 2019-Q4
Increased
56

T-MOBILE US INC

4.1M$514.8M2.6%$105.40+14.26%
4 qtrssince 2020-Q2
Increased
56

BOSTON SCIENTIFIC CORP

12.8M$495.6M2.5%$36.93+5.49%
3 qtrssince 2020-Q3
Decreased
0
XLNXXLNXDelisted

XILINX INC

3.7M$457.9M2.3%
2 qtrssince 2020-Q4
Increased
73

MICROSOFT CORP

1.9M$451.8M2.2%$136.50+63.36%
10 qtrssince 2018-Q4
Increased
58

FIDELITY NATIONAL INFO SERV

3.1M$441.8M2.2%$102.06+25.30%
10 qtrssince 2018-Q4
Decreased
0

META PLATFORMS INC-CLASS A

1.4M$412.1M2.0%$193.42+47.86%
10 qtrssince 2018-Q4
Increased
64

ARAMARK

10.9M$410.6M2.0%$25.86+1.12%
2 qtrssince 2020-Q4
Decreased
0

WABTEC CORP

4.9M$391.6M1.9%$62.25+24.67%
10 qtrssince 2018-Q4
Decreased
0

RAYTHEON TECHNOLOGIES CORP

4.8M$369.5M1.8%$63.35+8.25%
2 qtrssince 2020-Q4
Increased
52

CENTENE CORP

5.6M$359.5M1.8%$57.70+13.32%
5 qtrssince 2020-Q1
Decreased
0
XLRNXLRNDelisted

ACCELERON PHARMA INC

2.6M$352.6M1.8%
10 qtrssince 2018-Q4
Unchanged
0

MASTERCARD INC - A

985,920$351M1.7%$348.120.00%
1 qtr
New
71

BLACKSTONE INC

4.4M$330.3M1.6%$45.93+34.20%
5 qtrssince 2020-Q1
Increased
55
$20.1B
AUM
237
Positions
Q1 2021
Filing
Rating · 1.5
Quarterly Portfolio Change
+12%Q4'19$14.8B-21%Q1'20$11.7B+7%Q2'20$12.5B+16%Q3'20$14.5B+15%Q4'20$16.6B+21%Q1'21$20.1B
Activity profile
$ moved · Q1'21
New28%Increased41%Decreased22%Exited8%
Composition
Equity vs derivatives
Equity96%Puts4%Calls0%
Holding period
Avg 2.6 quarters
<1Q49%1-4Q22%1-2Y9%2Y+19%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $20.1B across 237 positions as of Q1 2021. Top holdings: SPY (4.4%), ALXN (4.4%), GOOG (4.2%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1.5/5.0.

Q1 2021 Summary

Active quarter - 122 new positions, 20 exits, 41 increased. Top move: ALXN (INCREASED, conviction 94). Portfolio: $20.1B across 237 positions.

Top holdings by portfolio weight

Total AUM$19B
ALXN4.39%
GOOG4.16%
IQV3.91%
WTW3.55%
AON2.81%
TMO2.62%
TMUS2.56%
BSX2.46%
XLNX2.28%
MSFT2.25%
Other2.20%

Portfolio allocation by GICS sector

Sectors10
Unknown28.41%
Healthcare24.72%
Financial Services14.54%
Communication Services11.77%
Technology8.48%
Industrials7.74%
Consumer Cyclical2.12%
Basic Materials1.59%
Utilities0.46%
Real Estate0.18%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Healthcare, Financial Services
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record60
Conviction43
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q3 2024 Q2 2026+8.5M shares+$314.1M
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 Q2 2026+9M shares+$755.7M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used